StockData
Bioventus Inc. logo

Bioventus Inc. (BVS) stock

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.60+0.14 (+1.34%)

Close on Nov 17, 2026Market cap $891.37MP/E 13.8Yield –

Bioventus price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Bioventus's price to sales ratio was 1.3× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.1× to 1.6×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.3×+0.4
2025Dec 31, 20250.9×−0.3
2024Dec 31, 20241.2×+0.6
2023Dec 29, 20230.7×+0.4
2022Dec 30, 20220.3×–

More Bioventus figures

See a number that looks wrong?